FACTBOX-Key players in the animal health business
July 30 |
July 30 (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) expanded its animal health business by buying the other half of Merial from its U.S. partner Merck (MRK.N) for $4 billion in cash, while opening the door for a bigger partnership. [ID:nLU307753]
Here are some details about the key players in the animal health sector:
* BAYER BAYG.DE:
Segments -Companion Animals and Farm Animals
Key Products - Advantage, Baytril, Drontal
Sales 2008 - 963 million euros
* BOEHRINGER INGELHEIM:
Segments - Food Producing Animals - Cattle, Swine, Companion Animals - Small animals, Horse
Key Products - Ingelvac, Enterisol, Mamyzin, Metacam, Ubrolexin, Express, Vetmedin, Ventipulmin
Sales 2008 - 467 million euros
* MERIAL:
Segments - Dogs, Cats, Swine, Cows, Avian, Equine
Key Products - Frontline, Ivomec, Heartgard, Eqvalan, Gastrogard, Ulcergard and Purevax.
Sales 2008 - $2.6 billion
Employees - 5,400
* NOVARTIS (NOVN.VX):
Segments - Pet Health, Livestock and Bioprotection
Key Products - Denagard, Fortekor, Milbemax, Neporex , Interceptor, Agita, Prac-tic
Employees: 2593
Sales 2008 - $1.1 billion
* SCHERING-PLOUGH/INTERVET SGP.N:
Segments -Vaccines and Pharmaceuticals for companion animals, ruminants, equine, pigs and poultry
Key Products - Butox,Cobactan, Continum, Galaxy, Vista, Nuflor, Homeaain, Receptal
Sales 2008 - $2.9 billion
* PFIZER (PFE.N):
Segments - Livestock, Companion Animal and Horses
Key products - Bovi-Shield Gold, Convenia, Draxxin, Excede, Revolution, Rimadyl
Sales 2008 - $2.8 billion
* WYETH WYE.N/ Fort Dodge:
Segments: Livestock and companion animals
Key Products - ProMeris, ProHeart 6, West Nile-Innovator, the Duramune vaccine line, CYDECTIN Pour-on, the Pyramid vaccine line, Quest and Quest Plus
Revenue 2008 - $1.1 billion
Employees - 3500
Sources: Reuters/Company websites
(Writing by Carl Bagh, Bangalore Editorial Reference Unit; Editing by David Cutler; editing by Simon Jessop)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints



Follow Reuters